Abstract:Clostridium difficile is a bacterial pathogen that causes serious and potentially fatal inflammatory disease of the colon. One strategy for targeting C. difficile infection is to development treatments that target bacterial virulence. Anti‐virulence strategies to treat C. difficile infection are attractive options to antibiotic therapy because the human microbiota is spared and damage to host tissue is minimized. The Tcd toxins, TcdA and TcdB, are the major virulence factors produced by C. difficile and mediate host cytotoxicity by glucosylating and inactivating Rho family GTPases using UDP‐glucose as a glucosyl donor. Glucosylation of Rho GTPases leads to cell rounding and eventually cell death. We used kinetic isotope effects (KIEs) and transition state theory to solve the transition state structure of the glycosyltransferase domain of TcdB (TcdB‐GTD). This permits the design of transition state analogues which are potent enzyme inhibitors. KIEs compare the chemical steps of enzymatic reaction rates with isotopically labeled substrates and unlabeled substrates and provide critical information on the catalytic mechanism, bond lengths and geometry at the transition state. KIE analysis on the glycohydrolase reaction of TcdB‐GTD supported the formation of a late, dissociative glucocation‐like transition state where positive charge develops on the anomeric carbon. Glucocationic transition states are best mimicked by cationic nitrogen groups at or near the anomeric carbon. Iminosugars contain a nitrogen atom in the sugar ring in place of oxygen and mimic glucocationic transition states. We tested iminosugars for inhibition of TcdB‐GTD and TcdA‐GTD. Isofagomine (Ki TcdB‐GTD = 1.4 µM and Ki TcdA‐GTD = 0.24 µM) and noeuromycin (Ki TcdB‐GTD = 10.6 µM and Ki TcdA‐GTD = 4.7 µM) were the most potent iminosugars identified. Isofagomine and noeuromycin were shown to exhibit an uncompetitive mechanism of inhibition suggesting that both iminosugars act by binding to the enzyme‐UDP complex. Isothermal titration calorimetry experiments with TcdB‐GTD supported this finding where isofagomine and noeuromycin could only bind to TcdB‐GTD in the presence of UDP with Kd = 0.133 µM and Kd = 0.4 µM respectively. In addition, the X‐ray crystal structure of TcdB‐GTD in complex with either Isofagomine or noeuromycin with UDP revealed the formation of an ion‐pair interaction between the cationic nitrogen atom of the iminosugar and the β‐phosphate of UDP. Finally, we confirmed that isofagomine and noeuromycin could prevent Tcd toxin‐induced cytotoxicity of IMR90 cells. Firstly, both iminosugars were able to prevent Tcd toxin‐induced cell rounding as visualized by light microscopy. Secondly, Western blot analysis of Tcd toxin treated IMR90 cell lysates revealed that both isofagomine and noeuromycin could prevent glucosylation of Rac1 by Tcd toxin. Isofagomine and noeuromycin are effective in preventing Tcd toxin action. Transition state analogues against TcdA and TcdB have the potential to be used as treatments for C. difficile infections.

Interaction of cytopathogenic toxin from Clostridium difficile with cells in tissue culture

Clostridium difficile toxin B inhibits the secretory response of human mast cell line-1 (HMC-1) cells stimulated with high free-Ca²⁺ and GTPγS

Clostridioides difficile Toxins: Host Cell Interactions and Their Role in Disease Pathogenesis

The N-terminus of the Clostridioides difficile transferase A component directs toxin activity and potency

Assessment Of Clostridium Difficile Infections By Quantitative Detection Of Tcdb Toxin By Use Of A Real-Time Cell Analysis System

Purified CDT toxins and a clean deletion within the CDT locus provide novel insights into the contribution of binary toxin in cellular inflammation and Clostridioides difficile infection

Clostridiumnovyi's Alpha-Toxin Changes Proteome and Phosphoproteome of HEp-2 Cells

PhosphoLipidome Alteration Induced by Clostridioides difficile Toxin B in Enteric Glial Cells

Induction of cytokines in a macrophage cell line by proteins of Clostridium difficile

Clostridioides difficile toxin A-mediated Caco-2 cell barrier damage was attenuated by insect-derived fractions and corresponded to increased gene transcription of cell junctional and proliferation proteins

Inhibition of EGFR/ErbB does not protect against C. difficile toxin B

Revisiting bacterial cytolethal distending toxin structure and function

Structural Dynamics of Receptor Recognition and Ph-Induced Dissociation of Full-Length Clostridioides Difficile Toxin B.

The Achilles Heel of Clostridioides difficile Infection?

The role of toxin A and toxin B in Clostridium difficile infection

Identification of an Epithelial Cell Receptor Responsible for Clostridium Difficile TcdB-induced Cytotoxicity

Cytolethal distending toxin modulates cell differentiation and elicits epithelial to mesenchymal transition

Functional analyses of epidemic Clostridioides difficile toxin B variants reveal their divergence in utilizing receptors and inducing pathology

CSPG4-dependent cytotoxicity for C. difficile TcdB is influenced by extracellular calcium and chondroitin sulfate

Screening of Bifidobacteria and Lactobacilli Able to Antagonize the Cytotoxic Effect of Clostridium difficile upon Intestinal Epithelial HT29 Monolayer

Characterization and development of new anti‐toxins targeting Clostridium difficile